Adelheid M E van der Torren

Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

C. Punt, M. Koopman, A. May, 2015, The Lancet.

Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer.

J. Verweij, H. V. van Doorn, D. ten Bokkel Huinink, 2014, European journal of cancer.